Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Dirk Grunhagen"'
Autor:
Guoying Zhou, Lisanne Noordam, Dave Sprengers, Michail Doukas, Patrick P. C. Boor, Adriaan A. van Beek, Remco Erkens, Shanta Mancham, Dirk Grünhagen, Anand G. Menon, Johan F. Lange, Pim J. W. A. Burger, Alexandra Brandt, Boris Galjart, Cornelis Verhoef, Jaap Kwekkeboom, Marco J. Bruno
Publikováno v:
OncoImmunology, Vol 7, Iss 7 (2018)
Purpose: Liver metastasis develops in >50% of patients with colorectal cancer (CRC), and is a leading cause of CRC-related mortality. We aimed to identify which inhibitory immune checkpoint pathways can be targeted to enhance functionality of intra-t
Externí odkaz:
https://doaj.org/article/860f7b5822ba4d95acd8859e33f3e7a5
Autor:
Nina J. Wesdorp, J. Michiel Zeeuw, Sam C. J. Postma, Joran Roor, Jan Hein T. M. van Waesberghe, Janneke E. van den Bergh, Irene M. Nota, Shira Moos, Ruby Kemna, Fijoy Vadakkumpadan, Courtney Ambrozic, Susan van Dieren, Martinus J. van Amerongen, Thiery Chapelle, Marc R. W. Engelbrecht, Michael F. Gerhards, Dirk Grunhagen, Thomas M. van Gulik, John J. Hermans, Koert P. de Jong, Joost M. Klaase, Mike S. L. Liem, Krijn P. van Lienden, I. Quintus Molenaar, Gijs A. Patijn, Arjen M. Rijken, Theo M. Ruers, Cornelis Verhoef, Johannes H. W. de Wilt, Henk A. Marquering, Jaap Stoker, Rutger-Jan Swijnenburg, Cornelis J. A. Punt, Joost Huiskens, Geert Kazemier
Publikováno v:
European Radiology Experimental, Vol 7, Iss 1, Pp 1-13 (2023)
Abstract Background We developed models for tumor segmentation to automate the assessment of total tumor volume (TTV) in patients with colorectal liver metastases (CRLM). Methods In this prospective cohort study, pre- and post-systemic treatment comp
Externí odkaz:
https://doaj.org/article/a19a493caa084001a45146bb529d450c
Autor:
Nina J. Wesdorp, MD, Karen Bolhuis, MD, Joran Roor, MSc, Jan-Hein T. M. van Waesberghe, MD, PhD, Susan van Dieren, MSc, PhD, Martin J. van Amerongen, MD, PhD, Thiery Chapelle, MD, PhD, Cornelis H. C. Dejong, MD, PhD, Marc R. W. Engelbrecht, MD, PhD, Michael F. Gerhards, MD, PhD, Dirk Grunhagen, MD, PhD, Thomas M. van Gulik, MD, PhD, John J. Hermans, MSc, MD, PhD, Koert P. de Jong, MD, PhD, Joost M. Klaase, MD, PhD, Mike S. L. Liem, MD, PhD, Krijn P. van Lienden, MD, PhD, I. Quintus Molenaar, MD, PhD, Gijs A. Patijn, MD, PhD, Arjen M. Rijken, MD, PhD, Theo M. Ruers, MD, PhD, Cornelis Verhoef, MD, PhD, Johannes H. W. de Wilt, MD, PhD, Rutger-Jan Swijnenburg, MD, PhD, Cornelis J. A. Punt, MD, PhD, Joost Huiskens, MD, PhD, Geert Kazemier, MD, PhD, for the Dutch Colorectal Cancer Group Liver Expert Panel
Publikováno v:
Annals of Surgery Open, Vol 2, Iss 4, p e103 (2021)
Objectives:. Compare total tumor volume (TTV) response after systemic treatment to Response Evaluation Criteria in Solid Tumors (RECIST1.1) and assess the prognostic value of TTV change and RECIST1.1 for recurrence-free survival (RFS) in patients wit
Externí odkaz:
https://doaj.org/article/d69dc45286be409c858ca7dfac232cd4
Publikováno v:
European Journal of Surgical Oncology. 49:e28
Autor:
Cornelis Verhoef, Koen Peeters, Olga Husson, Dirk Grünhagen, Pascal G Doornebosch, Lissa Wullaert, Kelly Raquel Voigt, Diederik J Höppener, Jennifer M J Schreinemakers, Maria Verseveld
Publikováno v:
BMJ Open, Vol 13, Iss 10 (2023)
Introduction Colorectal cancer (CRC) is the third most common type of cancer in the Netherlands. Approximately 90% of patients can be treated with surgery, which is considered potentially curative. Postoperative surveillance during the first 5 years
Externí odkaz:
https://doaj.org/article/67d91762cd1a4db990bb7ac9f9df1fd7
Autor:
Sheima, Farag, Lioe-Fee de, Geus-Oei, Winette T, van der Graaf, Frits, van Coevorden, Dirk, Grunhagen, Anna K L, Reyners, Pieter A, Boonstra, Ingrid, Desar, Hans, Gelderblom, Neeltje, Steeghs
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 59(2)
Autor:
Dirk Grünhagen, Maureen J B Aarts, Ferry A L M Eskens, Kristien B M I Keymeulen, Lukas B Been, Alexander van Akkooi, Mathilde Jalving, Margot E T Tesselaar
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Background Merkel cell carcinoma (MCC) is associated with high recurrence rates and poor survival when metastatic disease is present. The immune checkpoint inhibitor avelumab has shown high response rates (RRs) and durable responses in patients with
Externí odkaz:
https://doaj.org/article/fa9ada41a89c4dfb8d07a291b6836d46
Autor:
Lucia Campos Carrascosa, Adriaan A van Beek, Valeska de Ruiter, Michail Doukas, Timothy S Fisher, Keith Ching, Karlijn van Loon, Patrick P C Boor, Yannick S Rakké, Lisanne Noordam, Pascal Doornebosch, Dirk Grünhagen, Kees Verhoef, Wojciech G Polak, Jan N M IJzermans, Irene Ni, Yik Andy Yeung, Dave Sprengers, Jaap Kwekkeboom
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Background OX40 (CD134) is a costimulatory molecule of the tumor necrosis factor receptor superfamily that is currently being investigated as a target for cancer immunotherapy. However, despite promising results in murine tumor models, the clinical e
Externí odkaz:
https://doaj.org/article/e56e3eb9973e485888dbd8bd5af2b0dc
Autor:
Catherine Zhou, Marieke Louwman, Marlies Wakkee, Astrid van der Veldt, Dirk Grünhagen, Cornelis Verhoef, Antien Mooyaart, Tamar Nijsten, Loes Hollestein
Publikováno v:
Cancers, Vol 13, Iss 17, p 4431 (2021)
The characteristics and disease patterns of primary stage I and II cutaneous melanomas that progress to stage III or IV disease were investigated based on data from the Netherlands Cancer Registry (NCR). Data on stage III or IV melanomas at first dia
Externí odkaz:
https://doaj.org/article/a4cc83077be5486fa1c320a2ed6185cb